Physiological Saline Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2021 – 2027

Physiological Saline Market size is expected to grow significantly from 2019 to 2025.
 

Rising prevalence of chronic diseases such as cancer and diabetes should increase the demand for physiological saline. Cancer and other diseases create complications and interferes with the normal body functioning. Therefore, people suffering from such chronic illness require critical monitoring and are very often admitted in hospitals. This scenario proves beneficial for the industry growth as it increases the demand for physiological saline.
 

Favorable regulatory trends in developed economies positively impacts the physiological saline market growth. Regulatory authorities such as the U.S. FDA and Eu Commission frame several regulations and laws that ensures quality of physiological saline bottles being manufactured. Companies operational in the physiological saline industry have to comply to the rules set by regulatory authorities. This helps in minimizing the defects in the physiological saline bottles that should surge its demand thereby, augmenting the industry growth. However, few already existing physiological saline bags are not compatible with some of the drugs that might hamper industry growth to some extent.
 

Flexible bag segment had significant revenue share in 2018 and is predicted to foresee similar growth trends in the coming years. Industry players such as Fresenius Kabi and others involved in developing physiological saline manufacture superior quality flexible bags. For instance, Fresenius Kabi developed freeflex that is a 3^rd generation PVC-free variation of flexible bags. Newly developed flexible plastic bags are light weight and are highly compatible with the IV drugs. The packaging of these flexible bags is such that environmental changes have no impact on them. Above mentioned factors will favor the segmental growth.
 

Hospitals segment will grow considerably throughout the forecast timeframe. Increasing number of hospital admissions escalates the demand for physiological saline bottles. Patients suffering from chronic infections suffer from low WBC count and require continuous intake of saline to maintain the electrolyte balance in the body. Moreover, people prefer hospitals for treatments as compared to ASCs since, they are well-equipped with advanced medical devices and thus, escalating hospital admissions should enhance the segmental growth.
 

Asia Pacific physiological saline market will have significant growth in the coming years owing to favorable demographic trends. For instance, elderly population is high in Japan. Elderly population is susceptible to chronic infections positively influences the regional growth. Furthermore, emerging countries such as India and China have poor hygiene conditions that augments the prevalence of infectious diseases thereby elevating the demand for physiological saline bottles.
 

Industry players operational in physiological saline market include Baxter, Hospira (Pfizer), Fresenius Kabi, B. Braun, Otsuka, Kelun Group, CR Double-Cran, SSY Group and Cisen. These industry players adopt several strategic initiatives such as mergers, acquisitions and new product launch to maintain their market position. For instance, B.Braun launched EXCEL sterile physiological solution. This newly developed physiological saline has been extensively utilized during the surgical procedures due its superior quality. Therefore, introduction of new products will foster company’s growth.
 

Physiological Saline Market By Product Type, 2014-2025 (USD Million)

• Flexible bag
• Plastic bottle
• Glass bottle

Physiological Saline Market By End-users, 2014-2025 (USD Million)

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Others

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
• Latin America
  • Mexico
  • Brazil
  • Argentina
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE

Company Profiles:

• Baxter
• Hospira (Pfizer)
• Fresenius Kabi
• B. Braun
• Otsuka
• Kelun Group
• CR Double-Cran
• SSY Group
• Cisen

What Information does this report contain?